Welcome to the Kids' Library!

Antibiotics FDA needs to do more to ensure that drug labels contain up-to-date information : report

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012] 2012

Antibiotics, FDA has encouraged development, but needs to clarify the role of draft guidance and dev

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2017. 2017

Bottled water FDA safety and consumer protections are often less stringent than comparable EPA prote

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009] 2009

Challenges for the FDA the future of drug safety : workshop summary

Symposium on the Future of Drug Safety: Challenges for the FDA (2007 : Washington, D.C.)
Washington, DC : National Academies Press, c2007. 2007

COVID-19: federal efforts accelerate vaccine and therapeutic development, but tranparency needed on

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2020. 2020

A delicate balance FDA and the reform of the medical device approval process : hearing before the Sp

United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., U.S. G.P.O., 2011. 2011

Dietary supplements FDA may have opportunities to expand its use of reported health problems to over

United States. Government Accountability Office, author, issuing body.
[Washington, D.C.] : United States Government Accountability Office, 2013. 2013

Dietary supplements FDA should take further actions to improve oversight and consumer understanding

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009] 2009

Drug manufacturing : FDA should fully assess its efforts to encourage innovation : report to congres

United States. Government Accountability Office, author.
Washington, DC : United States Government Accountability Office, 2023. 2023

Drug safety better data management and more inspections are needed to strengthen FDA's foreign drug

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008] 2008

Drug safety FDA has begun efforts to enhance postmarket safety, but additional actions are needed :

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009] 2009

Drug safety FDA has conducted more foreign inspections and begun to improve its information on forei

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010] 2010

Drug safety, FDA has improved its foreign drug inspection program, but needs to assess the effective

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2017. 2017

Drug shortages, certain factors are strongly associated with this persistent public health challenge

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2016. 2016

FDA advisory committees process for recruiting members and evaluating potential conflicts of interes

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008] 2008

FDA food facility registry.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2009. 2009

FDA food safety inspection.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1991. 1991

FDA is issuing more postmarketing requirements, but challenges with oversight persist.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2016. 2016

FDA refusals of imported food products by country and category, 2005-2013

Bovay, John, author.
[Washington, D.C.] : United States Department of Agriculture, Economic Research Service, 2016. 2016

FDA regulation of blood and blood products : recent draft guidance on donor eligibility

Sussman, Jared S., author.
[Washington, D.C.] : Congressional Research Service, 2023- 2023

FDA to consider whether and how to lower permissible nicotine levels in cigarettes

Barry, Matthew B., author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

FDA user fees 2012 issues related to accelerated approval, medical gas, antibiotic development, and

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Printing Office, 2013. 2013

FDA user fees 2012 how innovation helps patients and jobs : hearing before the Subcommittee on Healt

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Printing Office, 2013. 2013

FDA warning letters : timeliness and effectiveness.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1999. 1999

FDA warning letters : trends and perspectives.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1999. 1999

FDA warns of youth epidemic of e-cigarette use, faces regulatory challenges

Green, Victoria R., author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

FDA's independent evaluation of its food safety programs

Nair, Amber D., author.
[Washington, D.C.] : Congressional Research Service, 2023- 2023

FDA's mammography inspections : while some problems need attention, facility compliance is growing :

United States. General Accounting Office.
Washington, D.C. : The Office, 1997. 1997

FDA's monitoring of postmarketing study commitments.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2006. 2006

Federal "right-to-try" legislation : legal considerations

Staman, Jennifer A., author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Federal rulemaking improvements needed to monitoring and evaluation of rules development as well as

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009] 2009

Food and Drug Administration approval and oversight of the drug Mifeprex : report to congressional r

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008] 2008

Food and Drug Administration better coordination could enhance efforts to address economic adulterat

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2011] 2011

Food and Drug Administration overseas offices have taken steps to help ensure import safety, but mor

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010] 2010

Food and Drug Administration response to heparin contamination helped protect public health; control

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010] 2010

Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Commi

United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

Food and Drug Administration's review process for products to treat rare diseases and neglected trop

United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.
Washington : U.S. G.P.O., 2011. 2011

Food labeling FDA needs to better leverage resources, improve oversight, and effectively use availab

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008] 2008

Food labeling FDA needs to reassess its approach to protecting consumers from false or misleading cl

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2011] 2011

Food safety and the Food and Drug Administration : hearing before a subcommittee of the Committee on

United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, author.
Washington : U.S. Government Publishing Office, 2022. 2022

Food safety agencies need to address gaps in enforcement and collaboration to enhance safety of impo

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2009] 2009

Food safety FDA can better oversee food imports by assessing and leveraging other countries' oversig

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012] 2012

Food safety FDA needs to reassess its approach to reducing an illness caused by eating raw oysters :

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2011] 2011

Food safety FDA should strengthen Its oversight of food ingredients determined to be Generally Recog

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2010] 2010

Food safety FDA's food advisory and recall process needs strengthening : report to congressional req

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012] 2012

Food safety improvements needed in FDA oversight of fresh produce : report to congressional requeste

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2008] 2008

Generic drugs : stakeholders views on improving FDA's information on patents : report to congression

United States. Government Accountability Office, author.
Washington, DC : United States Government Accountability Office, 2023. 2023

Infant formula shortage : FDA regulation and federal response

Sheikh, Hassan Z., author.
[Washington, D.C.] : Congressional Research Service, 2022- 2022

Innovation in America opportunities and obstacles : hearing before the Subcommittee on Competitivene

United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Competitiveness, Innovation, and Export Promotion.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2011. 2011

Medical devices FDA's approval of four temporomandibular joint implants : report to congressional re

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2007] 2007